KNSA KINIKSA PHARMACEUTICALS INTERNATIONAL PLC Business Restructuring 8-K Filing 2024 - Redomiciliation Proposal Kiniksa Pharmaceuticals proposes to change its place of incorporation from Bermuda to the United Kingdom, resulting in the creation of a new public holding company.Get access to all SEC 8-K filings of the KINIKSA PHARMACEUTICALS INTERNATIONAL PLC